Assessment of the flow-diverter efficacy for intracranial aneurysm treatment considering pre- and post-interventional hemodynamics.

Computational fluid dynamics Endovascular treatment Flow diverter Hemodynamics Intracranial aneurysms Virtual stent deployment

Journal

Computers in biology and medicine
ISSN: 1879-0534
Titre abrégé: Comput Biol Med
Pays: United States
ID NLM: 1250250

Informations de publication

Date de publication:
04 2023
Historique:
received: 23 12 2022
revised: 08 02 2023
accepted: 26 02 2023
pubmed: 7 3 2023
medline: 15 3 2023
entrez: 6 3 2023
Statut: ppublish

Résumé

Endovascular treatment of intracranial aneurysms with flow diverters (FD) has become one of the most promising interventions. Due to its woven high-density structure they are particularly applicable for challenging lesions. Although several studies have already conducted realistic hemodynamic quantification of the FD efficacy, a comparison with morphologic post-interventional data is still missing. This study analyses the hemodynamics of ten intracranial aneurysm patients treated with a novel FD device. Based on pre- and post-interventional 3D digital subtraction angiography image data, patient-specific 3D models of both treatment states are generated applying open source threshold-based segmentation methods. Using a fast virtual stenting approach, the real stent positions available in the post-interventional data are virtually replicated and both treatment scenarios were characterized using image-based blood flow simulations. The results show FD-induced flow reductions at the ostium by a decrease in mean neck flow rate (51%), inflow concentration index (56%) and mean inflow velocity (53%). Intraluminal reductions in flow activity for time-averaged wall shear stress (47%) and kinetic energy (71%) are present as well. However, an intra-aneurysmal increase in flow pulsatility (16%) for the post-interventional cases can be observed. Patient-specific FD simulations demonstrate the desired flow redirection and activity reduction inside the aneurysm beneficial for thrombosis formation. Differences in the magnitude of hemodynamic reduction exist over the cardiac cycle which may be addressed in a clinical setting by anti-hypertensive treatment in selected cases.

Identifiants

pubmed: 36878124
pii: S0010-4825(23)00185-3
doi: 10.1016/j.compbiomed.2023.106720
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

106720

Informations de copyright

Copyright © 2023 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Dr. Daniel Behme is a consultant for Acandis GmbH outside of the submitted work. Andreas Ding is an employee at Acandis GmbH and provided the geometric data of the DERIVO 2 flow diverter. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Auteurs

Janneck Stahl (J)

Research Campus STIMULATE, University of Magdeburg, Magdeburg, 39106, Germany; Department of Fluid Dynamics and Technical Flows, University of Magdeburg, Magdeburg, 39106, Germany. Electronic address: janneck.stahl@ovgu.de.

Laurel Morgan Miller Marsh (LMM)

Department of Mechanical Engineering, University of Washington, Seattle, WA, USA.

Maximilian Thormann (M)

University Clinic for Neuroradiology, University Hospital Magdeburg, Magdeburg, 39120, Germany.

Andreas Ding (A)

Acandis GmbH, Pforzheim, 75177, Germany.

Sylvia Saalfeld (S)

Research Campus STIMULATE, University of Magdeburg, Magdeburg, 39106, Germany; Department of Simulation and Graphics, University of Magdeburg, Magdeburg, 39106, Germany.

Daniel Behme (D)

Research Campus STIMULATE, University of Magdeburg, Magdeburg, 39106, Germany; University Clinic for Neuroradiology, University Hospital Magdeburg, Magdeburg, 39120, Germany.

Philipp Berg (P)

Research Campus STIMULATE, University of Magdeburg, Magdeburg, 39106, Germany; Department of Medical Engineering, University of Magdeburg, Magdeburg, 39106, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH